PHARMACEUTICAL COMPOSITION FOR TREATING MALIGNANT TUMOUR CONTAINING FUSION PROTEIN CONTAINING IL-2 PROTEIN AND CD80 PROTEIN, AND IMMUNE CONTROL POINT INHIBITOR Russian patent published in 2024 - IPC A61K38/17 A61K38/20 A61K39/395 C07K14/55 C07K14/705 A61P35/00 

Abstract RU 2828377 C1

FIELD: medicine; pharmaceutics.

SUBSTANCE: object 1 is a pharmaceutical composition for preventing or treating a malignant tumour, containing as active ingredients a dimeric fusion protein, containing a variant of IL-2, containing amino acid substitutions R38A and F42A in SEQ ID NO: 10, and an extracellular domain of the CD80 protein, and an immune control point inhibitor, which is selected from a group consisting of an anti-PD-1 antibody, an anti-PD-L1 antibody and an anti-TIGIT antibody. Object 2 is a method of preventing or treating a malignant tumour, comprising administering to an individual having a malignant tumour, a dimeric fusion protein comprising a variant of IL-2, containing amino acid substitutions R38A and F42A in SEQ ID NO: 10, and an extracellular domain of the CD80 protein, and an immune control point inhibitor, which is selected from a group consisting of an anti-PD-1 antibody, an anti-PD-L1 antibody and an anti-TIGIT antibody.

EFFECT: synergetic effect of dimeric fusion protein introduction in combination with immune control point inhibitor.

6 cl, 76 dwg, 8 tbl, 33 ex

Similar patents RU2828377C1

Title Year Author Number
FUSION PROTEIN COMPRISING IL-2 PROTEIN AND CD80 PROTEIN AND ITS USE 2019
  • Jang, Myung Ho
RU2811541C2
COMPOSITION FOR ANTICANCER TREATMENT CONTAINING NK-CELLS AND FUSION PROTEIN WHICH CONTAINS IL-2 PROTEIN AND CD80 PROTEIN 2020
  • Chan, Meun Kho
  • Khon, Chkhon-Pe
  • Yan, Tszun Eon
  • Kokh, Eun Dzhun
  • Li, Dzhun Sub
  • Chkhoi, Eun Dzhoo
RU2832136C1
PROTEINS WITH A DOUBLE FUNCTION AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM 2016
  • Kim, Jun Hwan
  • Lim, Seyoung
  • Seo, Minji
  • Choi, Hyun Ho
  • Kim, Dohoon
  • Ju, Mi Kyeong
  • Park, Ju-Young
  • Kim, Seul Gi
  • Lim, Sangmyoun
  • Kim, Jong Gyun
  • Nam, Su Youn
RU2741345C2
FGF21 FUSED WITH LONG-ACTING PROTEINS AND PHARMACEUTICAL COMPOSITION CONTAINING SAME 2016
  • Kim, Jun Hwan
  • Lim, Seyoung
  • Seo, Minji
  • Choi, Hyun Ho
  • Kim, Dohoon
  • Ju, Mi Kyeong
  • Park, Ju-Young
  • Choi, Byung Hyun
  • Lee, Jun Kyung
  • Kim, Jong Gyun
  • Nam, Su Youn
RU2741087C2
FUSION PROTEIN COMPRISING IL-12 AND ANTI-FAP ANTIBODY, AND USE THEREOF 2021
  • Kim, Donggeon
  • Ryu, Soomin
  • Lee, Dahea
  • Kim, Dongsu
  • Chang, Jihoon
  • Lee, Byoung Chul
RU2831612C1
NEW MODIFIED IMMUNOGLOBULIN Fc-FRAGMENT FUNCTION PROTEIN AND ITS USE 2020
  • Jin, Hyun-Tak
  • Nam, Eun Joo
  • Youn, Je-In
RU2800919C2
FUSED PROTEIN CONTAINING TGF-BETA RECEPTOR, AND ITS PHARMACEUTICAL USE 2018
  • Gu, Tszinmin
  • Lo, Syao
  • Tao, Vejkan
RU2776204C1
EXTRACELLULAR DOMAIN OF ALPHA SUBUNIT OF IgE Fc RECEPTOR, A PHARMACEUTICAL COMPOSITION CONTAINING IT AND A METHOD FOR ITS PRODUCTION 2019
  • Sung, Young Chul
  • Yang, Zungyoon
RU2796162C2
NOVEL FUSION PROTEIN SPECIFIC FOR CD137 AND PD-L1 2019
  • Pavlidu, Marina
  • Pattarini, Lyuchiya
  • Sholer-Dairel, Aliks
  • Rote, Kristina
  • Olvill, Shejn
  • Bel Ajba, Rashida
  • Khinner, Marlon
  • Peper, Zhanet
RU2818349C2
FUSION PROTEIN CONTAINING HUMAN LEFTY A PROTEIN VARIANTS AND ITS USE 2019
  • Chon, Sun-Yun
  • Li, Kyun U
  • Mun, Son Ke
  • Kan, Sun Chon
  • Chkhve, Pen-Ok
  • Kvak, Chon
  • Chan, Chon Uk
  • Kim, Chon Khen
RU2793631C2

RU 2 828 377 C1

Authors

Jang, Myoung Ho

Nam, Su Youn

Koh, Young Jun

Cho, Young-Gyu

Dates

2024-10-10Published

2020-11-27Filed